Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare

British Journal of Psychiatry

Volumn 195, Issue 6, 2009, Pages 545-550

  Kisely, Stephen ^a,b   Campbell, Leslie Anne ^c   Wang, Yan ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Capital District Health Authority   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; CANADA; CAROTID ENDARTERECTOMY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEALTH CARE; HEALTH CARE QUALITY; HEART CATHETERIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARANOIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPULATION RESEARCH; PRACTICE GUIDELINE; PSYCHOSIS; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; STROKE;

AGED; AGED, 80 AND OVER; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL ISCHEMIA; NOVA SCOTIA; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS; STROKE; UNIVERSAL COVERAGE;

EID: 72149093829     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.067082     Document Type: Article

References (45)

1. Lawrence DM, Jablensky AV, Holman CDJ, Pinder TJ. Mortality in Western Australian psychiatric patients. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 341-347
2. Lawrence DM, Holman CDJ, Jablensky AV, Hobbs MST. Death rate from Ischaemic heart disease in Western Australian psychiatric patients 1980-1998. Br S Psychiatry 2003; 182: 31-36
3. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000; 283: 506-511 (Pubitemid 30062867)
4. Druss BG, Bradford D, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001; 58: 565-572
5. Young JK, Foster DA. Cardiovascular procedures in patients with mental disorders. JAMA 2000; 283: 3198.
6. Jones LE, Carney CP. Mental disorders and revascularization procedures in a commercially insured sample. Psychosom Med 2005; 67: 568-576
7. Petersen LA, Normand SL, Druss BG, Rosenheck RA. Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? Health Serv Res 2003; 38: 41-63.
8. Lawrence D, Jablensky AV, Holman CD. Preventable Physical Illness in People with Mental Illness. University of Western Australia, 2001.
9. Kisely S, Cox M, Smith M, Lawrence D, Maaten S. Does inequitable access to cardiological or neurological procedures contribute to preventable mortality in people with mental illness? Can Med Assoc Journal 2007; 176: 779-784
10. Kapral MK, Wang H, Mamdani M, Tu JV. Effect of socioeconomic status on treatment and mortality after stroke. Stroke 2002; 33: 268-273 (Pubitemid 34052223)
11. Eagle, KA, Guyton GA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110: 1168-1176
12. Department of Health. National Service Framework for Coronary Heart Disease. Department of Health, 2000 (http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/ DH-4094275).
13. Tran CTT, Lee DS, Flintoft VF, Higgjnson L, Grant FC, Tu JV, et al. CCORT/CCS quality indicators for acute myocardial infarction care. Can J Cardiol 2003; 19: 38-45. (Pubitemid 36304698)
14. National Diabetes Surveillance System. Responding to the Challenge of Diabetes in Canada. First Report of the National Diabetes Surveillance System. Health Canada, 2003 (http://www.phac-aspc.gc.ca/ccdpc-cpcmc/ ndss-snsd/english/pubs-reports/pdf/WEB-NDSS-English-Report-nocover.pdf).
15. Kisely S, Lin E, Lesage A, Gilbert C, Smith M, Campbell LA, et al. Use of administrative data for the surveillance of mental disorders in 5 provinces. Can J Psychiatry 2009; 54: 571-575
16. Williams JI, Young W. Inventory of Studies on the Accuracy of Canadian Health Administrative Databases. Institute for Clinical Evaluative Sciences in Ontario, 1996.
17. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Ninth Revision (ICD-9). WHO, 1978.
18. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). WHO, 1992.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder (4th edn) (DSM-IV). APA, 1994.
20. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371 (Pubitemid 15107153)
21. Fremantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318: 1730-1737 (Pubitemid 29290470)
22. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. W Engl J Med 1992; 327: 669-677 (Pubitemid 24163853)
23. Yusuf S, Sleight P, Pogue J, Bosch R, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000; 342: 145-153 (Pubitemid 30051645)
24. Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. J Hypertens 2008; 26: 1282-1289
25. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. Prevention of death, myocardial Infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
26. Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 2006; 118: 321-333
27. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619
28. Bradford DW, Kim MM, Braxton LE, Marx CE, Butterfield M, Elbogen EB. Access to medical care among persons with psychotic and major affective disorders. Psychiatr Serv 2008; 59: 847-852
29. Kilbourne AM, Welsh D, McCarthy JF, Post EP, Blow FC. Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders. J Gen Intern Med 2008; 23: 1628-1633
30. Hippisley-Cox J, Parker C, Coupland C, Vinogradova Y. Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study. Heart 2007; 93: 1256-1262 (Pubitemid 47492915)
31. Roberts L, Roalfe A, Wilson S, Lester H. Physical health care of patients with schizophrenia in primary care: a comparative study. Fam Pract 2007; 24: 34-40. (Pubitemid 46454663)
32. Weiss AP, Henderson DC, Weilburg JB, Goff DC, Meigs JB, Cagliero E, et al. Treatment of cardiac risk factors among patients with schizophrenia and diabetes. Psychiatr Serv 2006; 57: 1145-1152 (Pubitemid 44204908)
33. Paszat LF, Mackillop WJ, Groome PA, Zhang-Salomons J, Schulze K, Holowaty E. Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med 1998; 21: 125-134 (Pubitemid 28306348)
34. Carney CP, Woolson RF, Jones L, Noyes R Jr, Doebbeling BN. Occurrence of cancer among people with mental health claims in an insured population. Psychosom Med. 2004; 66: 735-743 (Pubitemid 39332361)
35. Lawrence D, Jablensky AV, Holman CD, Threlfall TJ, Fuller SA. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatrica Scand 2000; 101: 382-388 (Pubitemid 30233004)
36. Kisely S, Sadek J, Mackenzie A, Lawrence D, Campbell LA. Excess cancer mortality in psychiatric patients. Can J Psychiatry 2008; 53: 753-761
37. Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006; 152: 922-927 (Pubitemid 44632939)
38. Shander D. Cardiovascular procedures in patients with mental disorders. JAMA 2000; 283: 3198-3199
39. Daumit GL, Pronovost PJ, Anthony CB, Guallar E, Steinwachs DM, Ford DE. Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry 2006; 63: 267-272 (Pubitemid 43345350)
40. Mailik S, Krumholz HM, Lin ZQ, Kasl SV, Mattera JA, Roumains SA, et al. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation 2005; 111: 271-277
41. Penn DL, Martin J. The stigma of severe mental illness: some potential solutions for a recalcitrant problem. Psychiatric Q 1998; 69: 235-247 (Pubitemid 28341014)
42. Waterreus AJ, Laugharne JD. Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm. Med J Aust 2009; 190: 185-189
43. Lambert TJ, Newcomer JW. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Med J Aust. 2009; 190: S39-42.
44. Lévesque LE, Brophy JM, Zhang B. The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults. Ann Intern Med 2005; 142: 481-489 (Pubitemid 40490913)
45. Crisanti AS, Love EJ. Mortality among involuntarily admitted psychiatric patients: a survival analysis. Soc Psychiatry Psychiatr Epidemiol. 1999; 34: 627-633